Somasegar Sivaramakichenane
CIK: 0002031410
Associated companies
Transaction History
| PATH | ▲ Buy | Grant | 16,064 | $0 | 6/26/2025 | View on chart |
| PATH | ▲ Buy | Grant | 47,694 | $608K | 9/5/2024 | View on chart |
| PATH | ▲ Buy | Grant | 16,064 | $0 | 6/26/2025 | View on chart |
| PATH | ▲ Buy | Grant | 47,694 | $608K | 9/5/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
UiPath Downgraded After Investor Day, Despite New Oracle Partnership
UiPath received a downgrade from analysts following its recent investor day, where the presentation failed to impress. This negative reaction contrasts with recent positive news, including a new test cloud availability on the Oracle Marketplace and recognition as a leader in adaptive process orchestration. The stock is currently trading near its 52-week low, reflecting the market's cautious stance despite these operational updates.
UiPath Downgraded After Investor Day, Despite New Oracle Partnership. UiPath received a downgrade from analysts following its recent investor day, where the presentation failed to impress. This negative reaction contrasts with recent positive news, including a new test cloud availability on the Oracle Marketplace and recognition as a leader in adaptive process orchestration. The stock is currently trading near its 52-week low, reflecting the market's cautious stance despite these operational updates.